N+1 Singer is using cookies to give you the best experience on our site.
By continuing to use our website without changing the settings, you are agreeing to our cookies policy. Read our Cookie Disclaimer here.
Our business provides capital raising services and advice to growth companies and investment funds.
FIND OUT HOW WE CAN HELP YOU
N+1 SINGER is proud to feature in the
FT 1000 Fastest Growing Companies in Europe.
Reuteurs Analyst Awards:
N+1 SINGER wins top stock picker for UK Retail
N+1 SINGER sponsors
The Sunday Times Tech Track 100
September 22, 2017
The Life Science team at N+1 Singer (analysts Jens Lindqvist and Sheena Berry, Brough Ransom in specialist sales and Aubrey Powell representing corporate finance) hosted a dinner last night for companies and investors in...
Realm Therapeutics plc (AIM: RLM) is a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology.
We are please to announce that it has successfully secured funding commitments to raise gross proceeds of...
September 20, 2017
Tim Cockroft is founder and CEO of N+1 Singer; James Clark, with 20 years’ experience in and around the funding of tech businesses, is currently the Head of Tech and Life Sciences in Primary...
This year, N+1 Singer celebrates 10 years of raising equity for the growth of the UK's small and mid-cap sector.
We are a partnership and as such can take a long-term view to deliver our clients strategies.
We have advised on more than 120 IPOs, secondary offerings and block trades, raising £2.5bn for 83 companies since 2013.